stage iia lung cancer ajcc v7 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

National Cancer Institute (NCI) (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadantiretroviral therapy

I am/have/hadegfr exon 19 deletion

I am/have/hadmonoclonal antibody therapy

I am/have/hadstage iia lung squamous cell carcinoma ajcc v7

I am/have/hadlung non-small cell squamous carcinoma

I am/have/hadlung cancer

I am/have/hadkaposi sarcoma

I am/have/hadstage iiia lung cancer ajcc v7

I am/have/hadplatelet count

I am/have/hadsquamous cell carcinoma of lung

I am/have/hadstage iiia lung squamous cell carcinoma ajcc v7

I am/have/hadsarcoma

I am/have/hadEGFR

I am/have/hadlung carcinoma

I am/have/hadsquamous cell carcinoma

I am/have/hadpd-l1

I am/have/hadnon-squamous non-small cell lung cancer

I am/have/hadsquamous cell lung carcinoma

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadHIV Infection

added new label for I am/have/had

more

I am looking for

I am looking forcisplatin

I am looking forcarboplatin

I am looking formonoclonal antibodies

I am looking forpembrolizumab

I am looking forpemetrexed

I am looking forgemcitabine

I am looking formonoclonal protein

I am looking forpaclitaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
all
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

cisplatin

antiretroviral therapy

egfr exon 19 deletion

monoclonal antibody therapy

stage iia lung squamous cell carcinoma ajcc v7

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.